Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 164.33M USD
- Enterprise value
- -55.11M USD
- Trailing P/E
- —
- Forward P/E
- -1.70
- Price / sales
- 7.65
- Price / book
- 0.75
- EV / EBITDA
- 0.41
- Beta
- 1.63
- Dividend yield
- —
- Profit margin
- 0.00%
- Return on equity
- -59.21%
- Debt / equity
- 0.26
- Earnings growth
- —
- Revenue growth
- +9.70%
- Free cash flow
- -71.25M USD
- Operating cash flow
- -113.91M USD
- Shares outstanding
- 31.42M
- Sector
- Healthcare
- Industry
- Biotechnology
Updated Sep 2, 2026, 4:11 AM